Furthermore, we found that hypermethylation of RARB and RASSF1A were independent predictors of poor overall survival in CRC patients, further emphasizing the potential usage of circulating hypermethylated DNA as biomarkers for CRC prognosis. The gene discussed is RASSF1; the disease is colorectal carcinoma.